Cytek Biosciences, Inc. (CTKB)

Last Closing Price: 5.92 (2026-11-18)

Income after Taxes (Quarterly)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Cytek Biosciences, Inc. (CTKB) had Income after Taxes of $-6.10M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$53.23M
$-6.10M
$22.02M
$31.21M
$61.65M
$-8.42M
$1.51M
$-6.91M
$-6.91M
Income after Taxes
$-6.10M
$-6.10M
$-6.10M
$-6.10M
$-8.42M
$-5.31M
130.36M
130.36M
$-0.05
$-0.05
Balance Sheet Financials
$378.94M
$20.61M
$67.21M
$446.14M
$84.95M
$0.10M
$39.84M
$124.79M
$321.35M
$290.63M
$321.35M
130.77M
Cash Flow Statement Financials
$-5.82M
$-21.86M
$2.61M
$90.85M
$67.19M
$-23.66M
$15.05M
--
--
Fundamental Metrics & Ratios
4.46
--
--
0.00
0.00
58.63%
-15.82%
-15.82%
--
-12.98%
-11.45%
$-11.63M
--
--
--
0.12
0.42
0.90
100.08
-1.90%
-2.10%
-1.37%
-1.90%
$2.46
$-0.09
$-0.04